We can expect the efficacy to be on the same order as other studies for replicel. 5% increase in density, rejuvenation of thinning hairs, possible immunity to further losses.
Science is quite consistent.
Sources?Shouldn't their phase 2 trials have been released around September last year? There were also talks about a release in Japan in the last quarter of 2018. Is it time to write off Shiseido from the wish-list as well?
Nothing has been delayed. Null.Announcement of results have been delayed until later this year.
As far as the clues can tell us, things don’t look too promising.
Are you 100% certain that Mr Kishimoto is announcing the results?The directer of the japanese trial Jiro Kishimoto will get the presentation at the hair congress spain this April
It's been clarified that the 5% referred to the phase I trial.We can expect the efficacy to be on the same order as other studies for replicel. 5% increase in density, rejuvenation of thinning hairs, possible immunity to further losses.
Science is quite consistent.
What's to occur within the next 6 months?That actually is not that bad..immunity that is.
I am wondering if the RCI-02 will be used?!
If so it may improve results.
I guess in 6 months we may know more.
So, it's just wishful thinking on your behalf.What is to occur..we may know if RCI-02 msy be used. According to Replicel it improves delivery of the product, hence improved outcome. I understand that the unit is about to be commercialized. Certainly a positive development for Replicel and patients if clsims are true.
I do understand that there was some friction between both companies. Fingers crossed that all is good again.
So, it's just wishful thinking on your behalf.
Cool!
So, it's just wishful thinking on your behalf.
Cool!
Immunity would be a win for a lot of us.We can expect the efficacy to be on the same order as other studies for replicel. 5% increase in density, rejuvenation of thinning hairs, possible immunity to further losses.
Science is quite consistent.
On the topic of “immunity”, I’ve read some speculation, or perhaps it’s fact, that the effects of the drug last only as long as a hair cycle, so continuous treatment would be needed in order to maintain any sort of immunity or growth benefits that it could have. Perhaps that means once every few years. Makes sense though.
The more I think about my own predicament, the more I realise that something like replicel to stop any further loss is one of my only hopes. In over 5 years of dealing with this disease, I’ve not found a single way to stop my hair from falling out. Growth is one thing. That doesn’t seem as difficult. Cessation of the downward spiral is an entirely other thing.. particularly for women.
Even if I can stop tbings where they are now.. I could likely manage.
I’ve long black hair.. very thin but passable. Much like many others I’m just disperste for the loss the stop.
Sources?
The two-year phase II clinical trial ended in the third quarter of 2018, and many, including me, expected the results to be announced in the last quarter (I expected personally a late September- early October release), but to no avail.
Shiseido had never even implied that the results would be released in 2018. That's what we falsely expected and what RepliCel alluded to.
Nothing has been delayed. Null.
Fake News!
Are you 100% certain that Mr Kishimoto is announcing the results?
It's been clarified that the 5% referred to the phase I trial.
There is no evidence (yet) that RCH-01 injections rejuvenate thinning hairs or of immunization.
Ms Cocona, you can do better than this.
You are clever enough.
What's to occur within the next 6 months?
I don't know why.So if nothing has been delayed, why weren’t the study results released last year?
N ODoes this mean that the 5% was a measurement across the whole nw1-7 area ?